1/40
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Smoking increases the risk of
coronary heart disease 2-4x
stroke 2-4x
lung cancer in men 25x
lung cancer in women 25.7x
causes cancer almost anywhere in the body
smoking during pregnancy causes
preterm delivery
stillbirth
low birth weight
SIDS
ectopic pregnancy
orofacial clefts in infants
correlated factors
25-44 years old
non-hispanic American Indians/alaskan natives
lower education levels
< federal poverty level
differs by state
mental illness
Second hand smoke in infants increases risk of
SIDS
respiratory infections
ear infections
severe asthma
slowed lung growth
marketing
cigarettes are the only marketed consumable products that, when used persistently, will kill half or more of its users
Dependence
nicotine induce and sustain chemical dependence
psychoactive effects
used in highly controlled or compulsive manner
reinforce behavioral patterns
EPA
class A carcinogen
no safe level of exposure for humans
gaseous and particulate (tar)
nicotine
distilled when burned
carried in tar droplets to small airways
absorbed into arterial circulation distributed throughout body
reaches brain in seconds
nicotine effects
brain:
decreases appetite, anxiety, tension
increases mood
cardiovascular:
increases heart rate, BP
withdrawal symptoms
irritability, frustration, anger
anxiety, depression
loss of concentration
impatience
insomnia, restlessness
other:
cravings
impaired performance
constipation
dizziness
cough
withdrawal timeline
manifest in 1-2 days
peak in 1 week
dissipate 2-4 weeks
appetite and weight gain may persist for >6 mo
drug interactions
reduces therapeutic efficacy
increased toxicity
CYPP450 enzyme inducer
caffeine exposure increased 56% (decrease caffeine during attempts to quit)
interacts with a hormonal contraceptive
increases clotting risk
increase of CV events
greater risk if >35 yo or > 15 cig/day
cigarette smokers die ____
10 years earlier than non-smokers
approach to quiting
no treatment
cold turkey
95% of attempts fail
tabacco cessation counseling
pharmacotherapy
counseling + pharmacotherapy
exclusions for self treatment
serious heart disease, including recent MI, irregular heartbeat, severe angina
uncontrolled HTN
pregnancy
breastfeeding
< 18 yo
Active PUD
5 A’s
ask patients if they use tobacco
advising users to quit
assess readiness to quit
assisting patients to quit
arranging follow-up care
Ask
do you ever smoke or use any type of tobacco?
Advise
clear, strong, and personalized
sensitive and convey concern
I strongly encourage you to quit, and I want to help
Assess
not all patients are ready to quit when approached
classifications
not ready to quit in the next month
ready to quit in the next month
recent quitter in past 6 mo
former user > 6 mo ago
Assist
be empathetic
acknowledge quitting is a challenge
encourage counseling and medication
2 steps:
helping make decision to quit
setting a quit date
Arrange
multiple counseling interactions preferred (increase ability to abstain)
follow up is crucial
week 1, month 1, periodically thereafter
manage AEs
behavioral tips
offer emotional support
pre-contemplation counseling
always ask permission first
use open-ended questions
motivational interviewing
5 R’s popular in smoking cessation
Develop discrepancy
patient is still smoking
know it is harmful
cannot acknowledge that quitting is important
human tendency not to think about it
lead an honest discussion with patient
readiness ruler
decisional matrix
readiness ruler
helps focus the gap between where the person has been, and where they want to be
decisional matrix
essentially a pro/con list for fair meeting
express empathy
understand patient’s point of view
reflect on patient’s perspective
NO judgement zone
amplify ambivalence
help bring quitting to the forefront of the patient’s mind
roll with resistance
humans resist change
avoid the righting reflex
support self efficacy
many lack confidence to change
maintain positive tones
pharmacotherapy for smoking cessation
all agents double quit rates
first line agents:
nicotine replacement therapy gum
NRT lozenge
NRT patches
NRT inhaler
NRT nasal spray
sustained release bupropion
varenicline
nicotine replacement therapy
MOA: stimulates the release of dopamine in the CNS
reduces symptoms of withdrawal
allows focus on behavior change
no exposure to carcinogens
lower, slower, and less variable plasma levels
AE: headache, insomnia, abnormal dreams
NRT counseling
do not use tobacco products while taking NRT
AE may occur: nausea, vomiting, hyper-salivation, perspiring, abdominal pain, dizziness, weakness, palpitations
NRT gum/lozenge
2mg < 30 mins after waking
4 mg > 30 mins after waking
various flavors
available in mini formulations
MOA: buffering agent helps absorption in buccal mucosa
dosing: time to first cigarette
peak: 30 mins
duration: 2-3 hrs
AE: unpleasant taste, mouth irritation, jaw soreness, hyper salivation, hiccups, dyspepsia
NRT gum use
chew and park method
chew slowly several times
stop after you feel a peppery sensation
park gum between cheek and gums
when taste/tingles dissipates resume chewing
repeat, rotating parking locations
gum last about 30 mins
do not exceed 24 pieces/day
NRT lozenge use
place in mouth and let dissolve
stangdard lozenge about 20-30 mins
mini lozenge about 10 mins
warm, tingling sensation
do not chew or swallow
rotate in mouth
do not exceed 20 lozenges/day
NRT patch
7mg, 14 mg, 21 mg
deliver continuous, low levels of nicotine
1 patch = 24 hours
> 10 cigs per day:
21 mg/day for 4 weeks
14 mg/day for 2 weeks
7 mg/day for 2 weeks
< 10 cigs per day:
14mg/day for 6 weeks
7mg/day for 2 weeks
AE: local skin irritation, sleep disturbances (remove patch at night)
How to use NRT patch
apply to clean, dry, hairless area
same time per day
potate patch site
apply firm pressure for 10 seconds
apply for no more than 24 hours
do not cut patches
may shower and swim
keep out of reach of children and pets
E-cig risks
decision making nad impulse control in teens
attention and leanring in teens
addiction
mood disorders
aerosol related lung damage
fires and explosions
Youth epidemic tied to vitamin E
Individuals with MI, serious arrhythmias, serious or worsening angina pectoris
use NRT with medical supervision
pregnancy/lactation
refer
individuals less than 18 yo
refer